诺诚健华-U上涨5.08%，报8.27元/股

金融界06-28

6月28日，诺诚健华-U盘中上涨5.08%，截至13:19，报8.27元/股，成交4460.04万元，换手率2.14%，总市值145.77亿元。资料显示，诺诚健华医药有限公司位于89 Nexus Way, Camana Bay, Grand Cayman, Cayman Islands，公司是一家专注于发现和开发治疗癌症和自身免疫性疾病的创新药物的生物医药公司，拥有一体化的生物医药平台，包括药物靶...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2446385547?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-06-28 13:19","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2446385547","market":"hk","top_or_hot":-1,"title":"诺诚健华-U上涨5.08%，报8.27元/股","media":"金融界","content":"<div>\n<p>6月28日，诺诚健华-U盘中上涨5.08%，截至13:19，报8.27元/股，成交4460.04万元，换手率2.14%，总市值145.77亿元。资料显示，诺诚健华医药有限公司位于89 Nexus Way, Camana Bay, Grand Cayman, Cayman Islands，公司是一家专注于发现和开发治疗癌症和自身免疫性疾病的创新药物的生物医药公司，拥有一体化的生物医药平台，包括药物靶...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062813223895e10b0f&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>诺诚健华-U上涨5.08%，报8.27元/股</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n诺诚健华-U上涨5.08%，报8.27元/股\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-06-28 13:19 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062813223895e10b0f&s=b><strong>金融界</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>6月28日，诺诚健华-U盘中上涨5.08%，截至13:19，报8.27元/股，成交4460.04万元，换手率2.14%，总市值145.77亿元。资料显示，诺诚健华医药有限公司位于89 Nexus Way, Camana Bay, Grand Cayman, Cayman Islands，公司是一家专注于发现和开发治疗癌症和自身免疫性疾病的创新药物的生物医药公司，拥有一体化的生物医药平台，包括药物靶...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062813223895e10b0f&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1161","symbol_name":"生物科技","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062813223895e10b0f&s=b","article_id":"2446385547","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062813223895e10b0f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2446385547","pubTimestamp":1719551981,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"6月28日，诺诚健华-U盘中上涨5.08%，截至13:19，报8.27元/股，成交4460.04万元，换手率2.14%，总市值145.77亿元。截至3月31日，诺诚健华-U股东户数1.77万，人均流通股9.94万股。2024年1月-3月，诺诚健华-U实现营业收入1.66亿元，同比减少12.44%；归属净利润-1.42亿元，同比减少1047.82%。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"688428":"诺诚健华","BK1161":"生物科技","BK1574":"生物医药B类股","09969":"诺诚健华"},"translate_title":"Nuocheng Jianhua-U rose 5.08% to 8.27 yuan per share","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"688428":0.9,"09969":1},"content_text":"6月28日，诺诚健华-U盘中上涨5.08%，截至13:19，报8.27元/股，成交4460.04万元，换手率2.14%，总市值145.77亿元。资料显示，诺诚健华医药有限公司位于89 Nexus Way, Camana Bay, Grand Cayman, Cayman Islands，公司是一家专注于发现和开发治疗癌症和自身免疫性疾病的创新药物的生物医药公司，拥有一体化的生物医药平台，包括药物靶目标识别、临床前评估、临床试验设计和执行、药物制造和质量控制，以及商业化生产和销售。公司已经建立了均衡的药物管线组合，主要研发方向是癌症和自身免疫性疾病治疗，这两个领域具有重大的市场机遇和协同效应。截至3月31日，诺诚健华-U股东户数1.77万，人均流通股9.94万股。2024年1月-3月，诺诚健华-U实现营业收入1.66亿元，同比减少12.44%；归属净利润-1.42亿元，同比减少1047.82%。","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2446385547"}